Job Summary
We are excited to announce that we have an opportunity for an intern to join the IV Therapy Marketing Division this summer 2025.
*U.S. work authorization required: Fresenius Kabi will not sponsor work visas or other employment authorization.
*Pay rate is $19.00-$21.00 per hour, depending on completed academic years
*Fresenius Kabi does not provide a housing stipend or relocation assistance for summer internships
*This position requires working onsite 3+ days per week.
Responsibilities
Work with PN marketing team on projects pertaining to
- existing product activations,
- launch activations,
- conference and meeting support,
- other projects to be assigned during the rotation.
Ideal Candidate
- Intern will have strong interest in marketing, digital marketing and understand basic marketing principles.
- Intern should also have an interest in healthcare marketing and be adaptable to working on multiple projects simultaneously.
Requirements
- Must commit to working 8-12 weeks this summer.
- Currently enrolled as a student at an accredited college or university program pursuing a related business field degree.
- Must have successfully completed at least one full year of college by June 2025 and planning to return to school at the end of the internship.
- U.S. work authorization required: Fresenius Kabi will not sponsor work visas or other employment authorization.
Additional Information
We offer an excellent salary and benefits package including medical, dental and vision coverage, as well as life insurance, disability, 401K with company contribution, and wellness program.
Fresenius Kabi is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, citizenship, immigration status, disabilities, or protected veteran status.
What We Do
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company’s products and services are used for the therapy and care of critically and chronically ill patients.
Its product portfolio comprises a range of highly complex biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs. Within biopharmaceuticals, Fresenius Kabi offers, among others, biosimilar drugs with a focus on autoimmune diseases and oncology. The company’s clinical nutrition offering includes a wide selection of enteral and parenteral nutrition products. In the segment of medical technologies, its offering includes vital disposables, infusions pumps, apheresis machines, cell therapy devices, and more. Fresenius Kabi puts essential medicines and technologies in the hands of people who help patients and finds the best answers to the challenges they face.
Following its strategy “Vision 2026”, which is a key part of the #FutureFresenius program of the Fresenius healthcare group, the company is furthermore committed to increase efficiencies in the therapy and care of patients and improve access to high-quality healthcare around the globe. Fresenius Kabi aspires to be leading globally in its product segments – all for the benefit of patients, its customers, and its stakeholders.
Fresenius Kabi Community Guidelines and User Information:
https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: https://www.fresenius-kabi.com/imprint
